A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

Summary

KTx recipients receiving cyclosporine-based immunosuppressive therapy, and in the opinion of the investigator would benefit from switch to a tacrolimus-based immunosuppression, will switch the immunosuppressive therapy to a tacrolimus-based one. Efficacy and safety of patients will be observed for 52 weeks.

Timeline

Start

2013-07-23

Primary completion

2015-03-31

Completion

2015-03-31

Outcome

Outcome not reported

Stopped (Enrollment): “Due to difficulty enrolling patients”

Drugs

Indications